Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patients
- 21 November 2023
- journal article
- letter
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Seroconversion after anti‐SARS‐CoV ‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals—Prospective observational cohort studyDermatologic Therapy, 2022
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studyThe Lancet Rheumatology, 2021